PBH Stock Forecast & Price Target

Prestige Consumer is poised to deliver strong growth and value for investors in the long term due to its diverse portfolio of leading brands, particularly in the healthcare niche, and its favorable market position. The company's strengths, including its low number of confirmed cases of New World Screwworm and its ability to treat the disease, along with initiatives to counter it, bode well for continued success. Key metrics, such as revenue growth and adjusted EBITDA, also demonstrate the company's strong performance potential. The potential catalysts for the stock are also significant, including a focus on balance sheet de-levering and measures to expand margins.

Prestige Consumer is facing several challenges that may impact their stock price in a negative way. These include the uncertain macro backdrop, increasing competition in the consumer healthcare market, and the impact of rising input costs on product margins. Additionally, the company's focus on expansion and capacity may have a negative effect on their financials and cash flow in the short term. With a high debt to adjusted EBITDA ratio and a lack of attractive M&A opportunities, Prestige Consumer may struggle to deleverage their balance sheet and generate positive FCF in the near future.